We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Is Molina Healthcare (MOH) Outperforming Other Medical Stocks This Year?
Read MoreHide Full Article
For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Molina (MOH - Free Report) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? A quick glance at the company's year-to-date performance in comparison to the rest of the Medical sector should help us answer this question.
Molina is one of 1184 individual stocks in the Medical sector. Collectively, these companies sit at #6 in the Zacks Sector Rank. The Zacks Sector Rank gauges the strength of our 16 individual sector groups by measuring the average Zacks Rank of the individual stocks within the groups.
The Zacks Rank is a successful stock-picking model that emphasizes earnings estimates and estimate revisions. The system highlights a number of different stocks that could be poised to outperform the broader market over the next one to three months. Molina is currently sporting a Zacks Rank of #2 (Buy).
Within the past quarter, the Zacks Consensus Estimate for MOH's full-year earnings has moved 2.8% higher. This shows that analyst sentiment has improved and the company's earnings outlook is stronger.
Based on the latest available data, MOH has gained about 11.1% so far this year. In comparison, Medical companies have returned an average of -17.9%. This means that Molina is outperforming the sector as a whole this year.
Another stock in the Medical sector, DocGo Inc. (DCGO - Free Report) , has outperformed the sector so far this year. The stock's year-to-date return is 5.8%.
Over the past three months, DocGo Inc.'s consensus EPS estimate for the current year has increased 34%. The stock currently has a Zacks Rank #2 (Buy).
Looking more specifically, Molina belongs to the Medical - HMOs industry, a group that includes 8 individual stocks and currently sits at #97 in the Zacks Industry Rank. This group has gained an average of 6% so far this year, so MOH is performing better in this area.
In contrast, DocGo Inc. falls under the Medical Services industry. Currently, this industry has 66 stocks and is ranked #140. Since the beginning of the year, the industry has moved -27.4%.
Investors with an interest in Medical stocks should continue to track Molina and DocGo Inc. These stocks will be looking to continue their solid performance.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Is Molina Healthcare (MOH) Outperforming Other Medical Stocks This Year?
For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Molina (MOH - Free Report) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? A quick glance at the company's year-to-date performance in comparison to the rest of the Medical sector should help us answer this question.
Molina is one of 1184 individual stocks in the Medical sector. Collectively, these companies sit at #6 in the Zacks Sector Rank. The Zacks Sector Rank gauges the strength of our 16 individual sector groups by measuring the average Zacks Rank of the individual stocks within the groups.
The Zacks Rank is a successful stock-picking model that emphasizes earnings estimates and estimate revisions. The system highlights a number of different stocks that could be poised to outperform the broader market over the next one to three months. Molina is currently sporting a Zacks Rank of #2 (Buy).
Within the past quarter, the Zacks Consensus Estimate for MOH's full-year earnings has moved 2.8% higher. This shows that analyst sentiment has improved and the company's earnings outlook is stronger.
Based on the latest available data, MOH has gained about 11.1% so far this year. In comparison, Medical companies have returned an average of -17.9%. This means that Molina is outperforming the sector as a whole this year.
Another stock in the Medical sector, DocGo Inc. (DCGO - Free Report) , has outperformed the sector so far this year. The stock's year-to-date return is 5.8%.
Over the past three months, DocGo Inc.'s consensus EPS estimate for the current year has increased 34%. The stock currently has a Zacks Rank #2 (Buy).
Looking more specifically, Molina belongs to the Medical - HMOs industry, a group that includes 8 individual stocks and currently sits at #97 in the Zacks Industry Rank. This group has gained an average of 6% so far this year, so MOH is performing better in this area.
In contrast, DocGo Inc. falls under the Medical Services industry. Currently, this industry has 66 stocks and is ranked #140. Since the beginning of the year, the industry has moved -27.4%.
Investors with an interest in Medical stocks should continue to track Molina and DocGo Inc. These stocks will be looking to continue their solid performance.